The amyloid cascade hypothesis

被引:96
作者
Korczyn, Amos D. [1 ]
机构
[1] Tel Aviv Univ, Sackler Sch Med, Sieratzki Chair Neurol, IL-69978 Tel Aviv, Israel
关键词
D O I
10.1016/j.jalz.2007.11.008
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The amyloid deposits in the brains of patients with Alzheimer's disease have attracted attention and are now considered not only an essential requirement for pathological diagnosis but also an important clue to the pathogenesis of the disease. This article looks critically at the basis of the "amyloid cascade hypothesis" to conclude that there are many issues that need to be resolved since they are inconsistent with the hypothesis. (C) 2008 The Alzheimer's Association. All rights reserved.
引用
收藏
页码:176 / 178
页数:3
相关论文
共 21 条
[1]   Amyloid load and cerebral atrophy in Alzheimer's disease:: An 11C-PIB positron emission tomography study [J].
Archer, Hilary A. ;
Edison, Paul ;
Brooks, David J. ;
Barnes, Jo ;
Frost, Chris ;
Yeatman, Toni ;
Fox, Nick C. ;
Rossor, Martin N. .
ANNALS OF NEUROLOGY, 2006, 60 (01) :145-147
[2]  
Bandiera T, 1997, CURR MED CHEM, V4, P159
[3]   NEUROPATHOLOGICAL STAGING OF ALZHEIMER-RELATED CHANGES [J].
BRAAK, H ;
BRAAK, E .
ACTA NEUROPATHOLOGICA, 1991, 82 (04) :239-259
[4]   Amyloid-β immunotherapies in mice and men [J].
Brendza, Robert P. ;
Holtzman, David M. .
ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2006, 20 (02) :118-123
[5]   The effects of APOE genotype on age at onset and progression of neurodegenerative diseases [J].
Chapman, J ;
Korczyn, AD ;
Karussis, DM ;
Michaelson, DM .
NEUROLOGY, 2001, 57 (08) :1482-1485
[6]   Effects of Aβ immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease [J].
Fox, NC ;
Black, RS ;
Gilman, S ;
Rossor, MN ;
Griffith, SG ;
Jenkins, L ;
Koller, M .
NEUROLOGY, 2005, 64 (09) :1563-1572
[7]   Molecular and cellular basis for anti-amyloid therapy in Alzheimer disease [J].
Gandy, S ;
Martins, RN ;
Buxbaum, J .
ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2003, 17 (04) :259-266
[8]   Clinical effects of Aβ immunization (AN1792) in patients with AD in an interrupted trial [J].
Gilman, S ;
Koller, M ;
Black, RS ;
Jenkins, L ;
Griffith, SG ;
Fox, NC ;
Eisner, L ;
Kirby, L ;
Rovira, MB ;
Forette, F ;
Orgogozo, JM .
NEUROLOGY, 2005, 64 (09) :1553-1562
[9]   Soluble protein oligomers in neurodegeneration:: lessons from the Alzheimer's amyloid β-peptide [J].
Haass, Christian ;
Selkoe, Dennis J. .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2007, 8 (02) :101-112
[10]  
Hardy John, 2006, Current Alzheimer Research, V3, P71, DOI 10.2174/156720506775697098